Skeletal Muscle Mass Influences Tolerability and Prognosis in Hepatocellular Carcinoma Patients Treated with Lenvatinib

BACKGROUND: Low skeletal muscle mass is significantly associated with severe adverse events (AEs) from chemotherapy, and low tolerability leads to decreased survival. We aimed to investigate whether body skeletal muscle mass is correlated with tolerability and prognosis in patients with hepatocellul...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Liver Cancer
Hauptverfasser: Uojima, Haruki, Chuma, Makoto, Tanaka, Yoshiaki, Hidaka, Hisashi, Nakazawa, Takahide, Iwabuchi, Shogo, Kobayashi, Satoshi, Hattori, Nobuhiro, Ogushi, Katsuaki, Morimoto, Manabu, Kagawa, Tatehiro, Tanaka, Katsuaki, Kako, Makoto, Koizumi, Wasaburo
Format: Artigo
Sprache:Inglês
Veröffentlicht: S. Karger AG 2020
Schlagworte:
Original Paper
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7206580/
https://ncbi.nlm.nih.gov/pubmed/32399433
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000504604
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge